image:
The EndoCompass Research Roadmap is now available as an open access supplement in the European Journal of Endocrinology
Credit: European Society of Endocrinology
The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today, 17 October 2025, the EndoCompass Research Roadmap: Directions for the Future of Endocrine Science. The supplement is published today in the European Journal of Endocrinology and will also appear in Hormone Research in Paediatrics in due course. The Roadmap is a major new initiative to align research efforts, improve funding strategies and increase the visibility of hormone-related health challenges across Europe.
Endocrine diseases – such as diabetes, thyroid disorders, cancer, obesity, infertility and many rare finishocrine diseases – affect millions of people across Europe. Yet research into hormone health remains underfunded and fragmented, accounting for less than 4% of Horizon 2020 biomedical and health research funding. EndoCompass aims to close this gap, setting out what’s required to create strategic and equitable funding a reality.
“EndoCompass is intfinished to serve as a compass for finishocrine research for the next 10 years. We hope it can inspire all those working in finishocrinology to ensure that research focutilizes on the highest priority questions. More broadly, we hope that the EndoCompass project raises awareness of the importance of finishocrinology and finishocrine research among policycreaters, funding agencies and the public, who often do not link major societal health problems, such as obesity and infertility, to finishocrinology,” declared Professor Martine Cools, ESPE Co-Chair of the EndoCompass Steering Group.
The Roadmap was developed over two years by 228 clinical and scientific experts from across Europe, toreceiveher with nine patient advocacy groups and 10 partner societies.
It identifies specific research requireds and opportunities across eight finishocrine specialties and five cross-cutting areas, including data and technology, environment, health inequalities and life-course transitions. These recommfinishations are intfinished to inform funding and policy decisions at European and national levels, enhance coordination in the field and ultimately contribute to better health outcomes for all.
“EndoCompass has been a huge collaborative effort, bringing toreceiveher more than 220 scientists, clinicians and patient representatives from across Europe. It reflects a shared recognition of the urgent required to align our research priorities and work toreceiveher to shape the future of finishocrine science and deliver better care and outcomes for patients. Ultimately, this is about improving hormone health and tackling some of Europe’s most pressing and under-recognised health challenges,” declared Professor Martin Fassnacht, ESE Co-Chair of the EndoCompass Steering Group.
The EndoCompass Roadmap has been developed as a practical resource for the finishocrine community to utilize, reference and share, and ensure hormone health receives the attention it deserves.
Read the full Roadmap here.
Here is a list of all the papers included in the EndoCompass supplement, along with DOI numbers for the European Journal of Endocrinology (DOI numbers for Hormone Research in Paediatrics will be available shortly):
Ch. 1 – Endocrinology in European research funding (Horizon 2020 analysis) – https://doi.org/10.1093/ejfinisho/lvaf067
Ch. 2 – Research roadmap for adrenal and cardiovascular finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf063
Ch. 3 – Research roadmap for calcium and bone finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf064
Ch. 4 – Research roadmap for finishocrine cautilizes and consequences of cancer – https://doi.org/10.1093/ejfinisho/lvaf066
Ch. 5 – Research roadmap for diabetes, obesity and metabolism – https://doi.org/10.1093/ejfinisho/lvaf065
Ch. 6 – Research roadmap for growth disorders – https://doi.org/10.1093/ejfinisho/lvaf070
Ch. 7 – Research roadmap for pituitary and neurofinishocrine tumour finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf035
Ch. 8 – Research roadmap for reproductive and developmental finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf069
Ch. 9 – Research roadmap for thyroid finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf010
Ch. 10 – Rare diseases in finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf072
Ch. 11 – Environmental finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf071
Ch. 12 – Endocrinology across the lifespan – https://doi.org/10.1093/ejfinisho/lvaf074
Ch. 13 – Endocrine laboratory medicine – https://doi.org/10.1093/ejfinisho/lvaf036
Ch. 14 – Artificial ininformigence in finishocrinology – https://doi.org/10.1093/ejfinisho/lvaf073
More information: www.ese-hormones.org/finishocompass
Method of Research
Commentary/editorial
Subject of Research
Not applicable
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the utilize of any information through the EurekAlert system.
Leave a Reply